Skip to main content

Table 1 Skull measurements in Apert syndrome mice and littermate controls

From: Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2+P253R mice

 

Measurements

Landmarks

+/P253R

(n = 10)

+/+ littermate

(n = 4)

+/S252W (n = 7)

+/+ littermate

(n = 11)

Skull length (rnsla -- rocc)1

9.29 mma

9.77 mm

9.42 mm* a

9.83 mm

Skull height (lpto-bas)1

4.78a

4.65

4.91a

4.70

Neurocranial width at squamosal bone (lpsq-rpsq)1

6.31

6.34

6.51*

6.46

Intercanthal distance

(lflac-rflac)1

3.67a

3.85

3.83a

3.95

Facial width at zygomatic process of temporal bone

(lzyt-rzyt)1

5.81

6.00

6.04a

6.11

Maxilla length (laalf-lptyp)1 **

4.27a

4.73

4.24a

4.81

Mandible length

(mlsin-mlang)1

4.31a

4.53

4.47a

4.69

Maxilla/mandible ratio

0.99

1.04

0.95

1.03

Palate length (laalf-lpns)1 **

3.36a

3.48

3.24a

3.50

Length of nasal region

(lnsla-lflac)***

2.50a

2.79

2.64a

2.74

Overall cranial base length (amsph-bas)

3.09a

3.19

3.25

3.28

Anterior cranial base length***

(amsph-lsyn)

1.60a

1.68

1.68

1.69

Posterior cranial base length

(lsyn-bas)

1.66

1.70

1.78

1.77

  1. aThe models were significantly different from their control littermates for these linear distances
  2. * Measures come from a sample size of 4.
  3. ** Contrasts between mutants and their control littermates indicated that Fgfr2+/P253Rwere significantly less affected than Fgfr2+/S252W
  4. *** Contrasts between models and their control littermates indicated that Fgfr2+/P253Rwere significantly more affected than Fgfr2+/S252W
  5. 1http://www.getahead.psu.edu for precise landmark definitions.
  6. (Ref. [38] Richtsmeier and Lele, 1993; Ref. [47] Lele and Richtsmeier, 2001)